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Objective: This study assessed clinical condition at midterm follow-up after total cavopulmonary connection for
a functionally univentricular heart performed on children younger than 5 years.
Methods: Thirty-four Fontan patients (median age 10.4 years, range 6.8–20.7 years, 22 boys, median follow-up
7.8 years, 5.0–17.8 years) underwent electrocardiography, Holter monitoring, bicycle exercise testing, cardiac
magnetic resonance imaging, and N-terminal prohormone brain natriuretic peptide (NT-pro-BNP) analysis.
Results: Twenty-three patients (68%) were in sinus rhythm. Holter monitoring demonstrated normal mean heart
rate, low maximal heart rate, and no clinically significant arrhythmias or sinus node dysfunction. With maximal
bicycle ergometry (n ¼ 19), maximum workload (60% of normal), maximum heart rate (90% of normal), and
maximal oxygen uptake (69% of normal) were all significantly lower in the Fontan group than in a control group
(P<.001). Variables of submaximal exercise indicated less efficient oxygen uptake during exercise in all Fontan
patients. Ejection fraction was lower than in control subjects (59% 13% vs 69% 5%, P<.001). Mean end-
diastolic and end-systolic volumes and ventricular mass were higher than in control subjects (P< .001). Mean
NT-pro-BNP levels were increased relative to reference values, but only 8 patients had levels above the upper
reference limit.
Conclusion: At midterm follow-up, Fontan patients were in acceptable clinical condition, with preserved global
ventricular function, moderately decreased exercise capacity, and NT-pro-BNP levels within reference range.
Systemic ventricular mass was elevated, however, suggesting contractility–afterload mismatch. Long-term
consequences for ventricular function merit further investigation.Earn CME credits at
http://cme.ctsnetjournals.org
The Fontan operation is a palliative procedure for patients
with a congenital heart defect that precludes biventricular
repair. These days, it is performed as a staged procedure
resulting in redirection of the systemic venous return to
the pulmonary circulation without interposition of a subpul-
monary ventricle. There have been important modifications
of the original concept, aimed at improving systemic venous
and pulmonary artery hemodynamics and at preventing late
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doi:10.1016/j.jtcvs.2008.12.027The Journal of Thoracic and Csequelae.1 Currently, total cavopulmonary connection
(TCPC), with either an intra-atrial lateral tunnel or an extrac-
ardiac conduit to connect the inferior caval vein to the
pulmonary artery, is the procedure of choice.
Morbidity and mortality have improved significantly in
recent years2; however, information on midterm and long-
term outcomes after Fontan operation according to current
techniques is sparse, because these patients are only just
reaching adolescence and adulthood. Although there are
several reports on clinical outcome after the Fontan opera-
tion,2-4 most of these retrospective studies include relatively
heterogeneous patient groups, with heterogeneous treatment
strategies. The results in these reports thus may not be appli-
cable to patients who have undergone Fontan completion in
the present era. Today’s policy, for example, is to perform
the TCPC at increasingly younger ages.
The objective of this study was to assess 5-year and later
clinical follow-up in a cohort of patients after TCPC at
young age, 5 years or younger. For this purpose, we per-
formed electrocardiography, bicycle exercise testing, assess-
ment of ventricular function with magnetic resonance
imaging (MRI), and assessment of N-terminal prohormone
brain natriuretic peptide (NT-pro-BNP). The last is known
to discriminate pediatric patients with cardiac disease and
closely correlates with ventricular function.5ardiovascular Surgery c Volume 138, Number 1 89
C
H
D
Congenital Heart Disease Robbers-Visser et alAbbreviations and Acronyms
BNP ¼ brain natriuretic peptide
EDVI ¼ end-diastolic volume index
EF ¼ ejection fraction
ESVI ¼ end-systolic volume index
LV ¼ left ventricle
MRI ¼ magnetic resonance imaging
NT-pro-BNP ¼ N-terminal prohormone
brain natriuretic peptide
OUES ¼ oxygen uptake efficiency slope
RQ ¼ respiratory quotient
RV ¼ right ventricle
TCPC ¼ total cavopulmonary connection
_VE ¼ pulmonary ventilation
_VO2 ¼ oxygen consumption
MATERIALS AND METHODS
Patients
A cross-sectional study of patients after Fontan completion was per-
formed. The following inclusion criteria were used: (1) initial Fontan com-
pletion (TCPC) between 1988 and 2001, with regular follow-up, at three
tertiary pediatric referral centers, (2) age at Fontan completion of 5 years
or younger, and (3) duration of follow-up since Fontan completion of at least
5 years. Exclusion criteria were as follows: (1) contraindications for MRI or
bicycle exercise testing and (2) inadequate communication, either because
of mental retardation or because of a language barrier. Medical records
were reviewed for patient characteristics and anatomic and operative details.
The study was approved by the Dutch Central Committee on Research in-
volving Human Subjects and all three institutional review boards. All sub-
jects, and/or their parents if required, gave informed consent.
Electrocardiography
A standardized 12-lead electrocardiogram was obtained for all patients to
determine rhythm status, QRS duration (in milliseconds), and QT interval
corrected for heart rate (in milliseconds). A 24-hour Holter monitoring
was performed in all patients on a day with usual activities.
Bicycle Exercise Testing
A Jae¨ger Oxycon Champion System (Viasys Healthcare, Hoechberg,
Germany), allowing breath-by-breath ergometry, was used for maximal
exercise testing. Subjects were continuously monitored with 12-lead electro-
cardiography and blood pressure measurements. Workload increased
stepwise with 10 to 20 W/min. For bicycle exercise testing, a group of
32 sex- and height-matched control subjects was selected. Patients and con-
trol subjects were encouraged to perform until exhaustion, defined as a respi-
ratory quotient (RQ) at peak exercise of at least 1.05. Twenty-eight control
subjects and 19 Fontan patients managed to perform until the RQ reached
or exceeded 1.05. Eight patients with a submaximal exercise test did reach
RQs of at least 1.00. The patients with RQs less than 1.05 were younger
than those with RQs of at least 1.05 (10.0  2.5 years vs 13.2  3.7 years,
P ¼ .011). In the control group, subjects with RQs less than 1.05 were
also younger than subjects with RQs of at least 1.05 (8.9  0.8 years
vs 12.7  3.4 years, P< .001).
In all patients and control subjects, two variables of submaximal exercise
were assessed: (1) the slope of oxygen uptake versus exercise intensity,
according to the method of Reybrouck and colleagues,6 and (2) the oxygen
uptake efficiency slope (OUES), according to the method of Baba and90 The Journal of Thoracic and Cardiovascular Surcoworkers,7 as the linear relationship between log of pulmonary ventilation
( _VE) and oxygen consumption ( _VO2). These two variables are a measure of
the efficiency of the system in extracting oxygen during exercise and of use
in the periphery. A higher slope indicates a more efficient oxygen uptake.
Because Giardini and associates8 recently reported nonlinearity of the rela-
tionship between the log of _VE and _Vo2 throughout the exercise test for hyp-
oxemic patients who have undergone the Fontan operation, we first
validated the linearity of this relationship for patients who performed a max-
imal exercise test. Maximum workload (in watts), maximum heart rate (in
beats per minute), and maximum _VO2 ( _VO2max in milliliters per kilogram
per minute) were obtained for patients and control subjects with RQs of
at least 1.05.
Magnetic Resonance Imaging
Cardiac MRI was performed in all patients on a Signa 1.5-T whole-body
MRI system (General Electric, Milwaukee, Wis). Dedicated phased-array
cardiac surface coils were placed over the thorax. Patients were monitored
by vector cardiographic gating and blood pressure monitoring.
A multiphase, multislice volumetric data set was acquired with a fast
2-dimensional cine scan that used steady-state free precession. From 10 to
12 contiguous slices were planned parallel to the atrioventricular valve
plane of the systemic ventricle to cover the heart from base to apex. Imaging
parameters were as follows: slice thickness 7 to 10 mm, interslice gap 0 mm,
field of view 280 to 370 mm, phase field of view 0.75, matrix 160 3
128 mm, repetition time 3.5 ms, echo time 1.5 ms, flip angle 45, and
mean in-plane resolution 2 mm2. All images were acquired without breath
holding and were built up during multiple heart beats to eliminate the effects
of respiration on caval vein and pulmonary artery flow dynamics, with 3
signal averages.
Analysis was performed with a commercially available Advanced
Windows workstation (General Electric Medical Systems). The ventricular
volumetric data set was quantitatively analyzed with the AW 5.1 version of
the MR Analytical Software System (Medis Medical Imaging Systems, Lei-
den, The Netherlands). With manual detection of endocardial and epicardial
borders in end-systole and end-diastole, the following parameters were cal-
culated: end-diastolic and end-systolic volumes indexed for body surface
area (EDVI and ESVI, respectively), stroke volume index, ejection fraction
(EF), and systemic ventricular mass index. Ventricular volumes and masses
were defined as the sum of the volumes and masses of the systemic ventricle
and any hypoplastic chamber present. Data were compared with reference
data from 60 healthy children aged 8 to 17 years.9
NT-pro-BNP Analysis
Blood samples were taken from a peripheral vein after 30 minutes’ rest in
the supine position. Plasma and serum were separated immediately after
sample collection and stored at80C. NT-pro-BNP was measured with
the Elecsys electrochemiluminescence immunoassay (Roche Diagnostics,
Mannheim, Germany). We preferred the determination of NT-pro-BNP
for its stability in whole blood, its independence from exercise and position,
and its longer half-life in serum than brain natriuretic peptide (BNP) itself.10
Data were compared with reference data from a study that used an identical
analysis method.10,11 Expected mean values were calculated according to
the following equation10: NT-pro-BNP ¼0.3707 3 ageþ 12.346. The
upper reference limit was defined as the 97.5th percentile from the study
of Albers and coworkers.11
Statistical Analysis
Continuous data were tested for normality with the Kolmogorov–
Smirnov test. Values of NT-pro-BNP were log10 transformed to obtain
approximately normal distribution. Data with a normal distribution are
expressed as mean  SD, whereas the median and range are shown for
data with a nonnormal distribution. Differences in continuous data be-
tween groups of patients were evaluated with the Student t test, orgery c July 2009
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sented as counts and percentages, and differences between groups of
patients were evaluated with c2 or Fisher exact tests, as appropriate.
Univariable regression analyses were performed to study the interrelation
of NT-pro-BNP with the following: (1) demographic variables, (2) mea-
sures of systemic ventricular function and volumes acquired with CMR
imaging, and (3) physical exercise response. They were also performed
to study the relationship between ventricular mass and EF. Analyses
were performed with the SPSS-PC statistical software package version
14.0 (SPSS, Inc, Chicago, Ill).
RESULTS
Patients
We identified 100 patients who had undergone a TCPC in
the period between 1988 and 2001 and were alive at the start
of the study. The following patients were excluded: (1) 23
patients with Fontan completion at an age later than 5 years,
(2) 8 patients with pacemaker placement, (3) 5 patients with
hemiplegia or quadriplegia, (4) and 10 patients with inade-
quate communication. Of 54 eligible patients, 34 patients
(22 boys) participated in this study. There were no differ-
ences between participants and nonresponders in patient,
procedural, and follow-up characteristics.
Median age was 10.4 years (6.8–22.2 years). Mean age at
Fontan completion was 3.0  1.1 years. Median weight was
13.9 kg (8.9–22.0 kg). Median follow-up after Fontan
completion was 7.8 years (5.0–17.1 years). Twenty-seven
patients had an intra-atrial lateral tunnel; 7 patients had an
extracardiac conduit. Most patients (n ¼ 28, 82%) had
undergone staged procedures, with a bidirectional Glenn
anastomosis before completion of the Fontan circulation at
a median age of 1.0 years (0.2–3.8 years). Median interval
between bidirectional Glenn shunt and Fontan completion
was 1.7 years (0.5–3.3 years). Four patients had fenestrated
TCPCs because of hemodynamic indications. In 1 case the
fenestration closed spontaneously; another patient under-
went catheter-based closure of the fenestration.
The dominant ventricle was a morphologically right
ventricle (RV) in 16 patients, 6 of whom had hypoplastic
left heart syndrome. The dominant ventricle was a morpho-
logically left ventricle (LV) in 17 patients, 7 of whom had
tricuspid atresia. In 1 patient, ventricular morphology could
not be determined. There was 1 patient with right isomerism
and 1 patient with left isomerism, with normal systemic
venous connections.
Most patients (n ¼ 21) had a normal resting oxygen satu-
ration of at least 95%; however, 10 patients were mildly
hypoxemic (oxygen saturation 90%–94%) and 3 patients
had an oxygen saturation below 90% (2 with fenestrated
intra-atrial lateral tunnels, the other with a baffle leak after
an unfenestrated Fontan operation). The New York Univer-
sity pediatric heart failure index12 (score of 0 meaning no
heart failure, score of 30 meaning severe heart failure) was
between 4 and 9 in this patient group. Five patients were
receiving angiotensin-converting enzyme inhibitors, andThe Journal of Thoracic andno patients were receiving diuretics or antiarrhythmic
medication.
Electrocardiography
Twenty-three patients were in sinus rhythm. Nine patients
had a supraventricular rhythm, and in 2 patients the rhythm
was of atrioventricular nodal origin. Mean QRS duration
was 100  13 ms. Mean QT interval corrected for heart
rate was 419  26 ms. There was no difference in QRS
duration and QT interval corrected for heart rate between pa-
tients with a dominant RV and those with a dominant LV.
None of the patients had any symptoms during 24-hour
Holter monitoring. Thirty patients showed sinus rhythm,
with frequent episodes of supraventricular rhythm in 2
patients and occasional episodes of supraventricular rhythm
in 12 patients. Two patients had occasional episodes with
a junctional rhythm. Mean heart rate was 79  12 beats/
min. Mean maximum heart rate was 168  18 beats/min
(128–200 beats/min), and mean minimum heart rate was
46  9 beats/min (33–67 beats/min). There was no differ-
ence between patients with a lateral tunnel and patients
with an extracardiac conduit (Table 1). There were no car-
diac pauses longer than 1.9 seconds. Only 1 patient (age
17 years, 16 years after Fontan completion for hypoplastic
left heart syndrome) had frequent premature atrial contrac-
tions. Shortly after the investigations for this study, this
patient had atrial flutter.
Bicycle Exercise Testing
Bicycle exercise testing was successfully completed by 32
patients and all control subjects. One patient (age 6.8 years,
height 117 cm) was too small for our ergometer. Breath-by-
breath analysis failed because of a technical problem in
1 other case.
Relative to the control group (n ¼ 28), Fontan patients
(n ¼ 19) reached a lower maximum workload (60% of
control subjects, 146  61 W vs 87  30 W, 3.2 
0.6 W/kg vs 2.1  0.5 W/kg, P< .001) and lower max-
imum heart rate (90% of control subjects, 184  12
beats/min vs 166  15 beats/min, P ¼ .001). _VO2max
was significantly lower in Fontan patients (69% of control
subjects, 48  7 mL/(min $ kg) vs 33  8 mL/(min $ kg),
P< .001).
Among patients who completed a maximal exercise test
(n¼ 19), there was no difference between OUES for the en-
tire exercise test and OUES during the second half of the test
(1.57 0.38 and 1.50 0.57, respectively, P¼ .38). OUES
during the first half of the test (1.46  0.38) was lower than
OUES of the entire test (P ¼ .046). In hypoxemic patients,
this comparison of OUES yielded the same results. The
relationship between the log of _VE and _VO2 was not consid-
ered linear, but OUES of the second half of the test was con-
sidered to be representative of the OUES of the complete
test.Cardiovascular Surgery c Volume 138, Number 1 91
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Variable ILT ECC P value
Age (y, median and range) 10.3 (6.8–20.7) 10.3 (8.0–14.1) .90
Age at Fontan completion (y, median and range) 2.9 (1.0–5.0) 2.8 (2.3–4.1) .56
Follow-up (y, median and range) 7.7 (5.0–17.1) 7.9 (5.2–10.0) .84
Oxygen saturation at rest (%, median and range) 95% (87%–100%) 97% (95%–98%) .14
Blood pressure at rest (mm Hg, mean  SD)
Systolic 110  7 133  9 .013
Diastolic 77  15 73  6 .83
NT-pro-BNP (pmol/L, median and range) 13 (3–57) 7 (4–37) .06
OUES (mean  SD) 1.55  0.52 1.66  0.37 .72
OUEIS (mean  SD) 8.8  1.3 10.0  1.2 .59
EDVI (mL/m2, mean  SD) 78  15 79  16 .22
ESVI (mL/m2, mean  SD) 36  17 24  6 .13
Ventricular mass index (g/m2, mean  SD) 70  16 73  7 .79
Ejection fraction (%, mean  SD) 56%  14% 69%  4% .019
Heart rate (beats/min, mean  SD)
Mean 77  13 79  14 .71
Maximum 161  16 175  9 .28
Minimum 46  10 47  8 .79
ILT, Intra-atrial lateral tunnel; ECC, extracardiac conduit; NS, not significant; NT-pro-BNP, N-terminal prohormone brain natriuretic peptide; OUES, oxygen uptake efficiency
slope; OUEIS, oxygen uptake/exercise intensity slope; EDVI, end-diastolic volume index; ESVI, end-systolic volume index.Both variables of submaximal exercise were higher in
control subjects (n ¼ 32) than in patients (n ¼ 32). The
OUES was 2.00  0.66) in control subjects and 1.50 
0.44 in patients (P¼ .002). The slope of oxygen uptake ver-
sus exercise intensity was 9.7  0.9) in control subjects and
8.9  1.3 in Fontan patients (P ¼ .004).
There was no difference between patients with a dominant
RV and patients with a dominant LV in variables of maximal
exercise (8 RV, 10 LV) and submaximal exercise (14 RV,
17 LV). There were also no differences between different
Fontan types.
Magnetic Resonance Imaging
Mean EDVI was 77  16 mL/m2, mean ESVI was 33 
14 mL/m2, mean EF was 59% 12%, and mean mass index
was 71  19 g/m2. EF tended to be lower in patients with
a dominant RV than in patients with a dominant LV (RV
EF 54% 14%, LV EF 64%9%, P¼ .053). EF was sig-
nificantly higher in the patients with an extracardiac conduit
(Table 1). There were no differences in volumes and mass
between RV and LV morphologic types. RV ESVI tended
to be higher than LV ESVI, but this difference was not sta-
tistically significant (P ¼ .17).
Relative to reference data for ventricular volumes and
mass,9 end-diastolic volume (96  35 mL vs 87  31 mL,
P ¼ .017), end-systolic volume (41  26 mL vs 24 
11 mL, P< .001), and systemic ventricular mass (91 
48 g vs 72  33 g, P< .001) were higher in patients. EF
was lower in patients than in control subjects (systemic ven-
tricle EF 59%  12% vs LV EF 69%  5%, P< .001).
Among patients, higher mass was associated with poorer
EF (P ¼ .027; b ¼.11).92 The Journal of Thoracic and Cardiovascular SurgNT-pro-BNP Levels
Blood sample collection was successful in 28 patients.
Median level of NT-pro-BNP was 11.5 pmol/L
(2.9–57.0 pmol/L). Relative to reference studies for NT-
pro-BNP with an identical analysis method,10,11 mean
NT-pro-BNP levels were higher than expected (mean NT-
pro-BNP in Fontan patients 18.0  15.2 pmol/L, expected
mean NT-pro-BNP 8.1 1.4 pmol/L, P¼ .002). Eight Fon-
tan patients (29%) had NT-pro-BNP levels above the upper
reference limit (7 lateral tunnel TCPCs, 1 extracardiac con-
duit TCPC). Ages and follow-up times of these 8 patients did
not differ from ages and follow-up times of the patients with
NT-pro-BNP within the reference range. There were no dif-
ferences in exercise response (maximum workload,
maximum heart rate, _VO2max, OUES, oxygen uptake versus
exercise intensity slope) or systemic ventricular volumes,
function, and mass between patients with NT-pro-BNP
above the 97.5th percentile and the remaining group.
NT-pro-BNP levels did not differ between patients with
a dominant RV and patients with a dominant LV. NT-pro-
BNP was lower in patients with an extracardiac conduit
(Table 1). Univariable regression analysis did not identify
any significant relationships between NT-pro-BNP and
age, follow-up time, variables of exercise testing (heart
rate increase, maximum workload, _VO2max, OUES, oxygen
uptake versus exercise intensity slope), or MRI variables
(EDVI, ESVI, EF, mass).
DISCUSSION
This study shows acceptable clinical conditions in
a patient group 5 to 18 years after Fontan completion at
younger than 5 years. In this patient cohort, all patientsery c July 2009
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tative of the current treatment policy.
In our study, 68% of patients were in sinus rhythm, and no
patients were receiving antiarrhythmic medication. Only
1 patient had frequent premature atrial contractions (and
had atrial flutter shortly after this investigation), and no
patients showed signs of clinically relevant sinus node dys-
function. Although patients with pacemakers were excluded
from this study, they comprised only 7% of the complete co-
hort. The prevalence of arrhythmias after Fontan operation
varies with the type of modification. The atriopulmonary
connection has been identified as a risk factor by several
groups,2,13 with a prevalence of atrial tachyarrhythmias at
long-term follow-up of 29% in these patients.13 Prevalence
of atrial tachyarrhythmias in lateral tunnel type TCPC is
about 15% to 20% at midterm to long-term follow-
up.2,4,13 Although in theory atrial tachyarrhythmias should
be less frequent with extracardiac conduit TCPC, prevalence
has been reported to be as great as 11% in a large cohort at
midterm follow-up.3 Other risk factors for development of
atrial tachyarrhythmias are older age at Fontan completion,
longer duration of follow-up, and early postoperative atrial
tachyarrhythmias.4,13 In this study, all patients underwent
Fontan completion younger than 5 years of age, a possible
explanation for the absence of arrhythmias in this study
group. Further follow-up, however, is necessary to determine
the prevalence of arrhythmias long term after Fontan
completion.
Although global ventricular function was good in this
study, maximal exercise capacity was only 60% of normal.
This is comparable to outcomes of maximal exercise capac-
ity in 166 Fontan patients in a recent study from the Pediatric
Heart Network.14 _VO2max and peak heart rate in this study
and our study were also comparable. The cause for impaired
exercise capacity may be of cardiac, pulmonary, or muscular
origin. Recently, we combined MRI with low-dose dobut-
amine stress testing to demonstrate an impaired preload re-
serve and an inadequate reaction of the pulmonary
vasculature in Fontan patients.15,16 The resultant inability
to increase stroke volume with stress testing could in part
be responsible for the well-known impairment in exercise
capacity. In contrast to others,17 we did not find a difference
in exercise capacity between patients with a dominant LV or
RV, but our subgroups were small.
The OUES and the oxygen uptake versus exercise inten-
sity slope are two measures of submaximal exercise that in-
tegrate the contributions of the cardiovascular, pulmonary,
and muscular systems to exercise capacity. Because of their
linearity, they are good indicators of maximal exercise capac-
ity, even when maximal exercise is not possible or desirable.
The OUES and oxygen uptake versus exercise intensity slope
both indicate how effectively oxygen is extracted and used in
the body.6,7 The steeper the slope is, the better the cardio-
vascular, pulmonary, and muscular systems work duringThe Journal of Thoracic andexercise. The results in this study indicate a decreased effi-
ciency of the system to extract oxygen, as was demonstrated
by Giardini and coworkers8 in a small group of Fontan pa-
tients. As in that study,8 the relationship between log _VE
and _VO2 was not linear throughout the exercise test, but
only for the second half of the exercise test. Therefore the
OUES is not a good indicator of maximal exercise capacity
in patients who manage to perform the exercise test only
briefly (which was not the case in our study). Giardini and
coworkers8 hypothesized that hypoxemia might be the cause
of this nonlinear relationship.
There have been a limited number of studies on global ven-
tricular function and volumes, as assessed with MRI, in pa-
tients after the Fontan operation. Recently, a large cohort
of children was reported on by the Pediatric Heart Network.4
In that study, a subgroup of 161 children underwent MRI.
Data in the Network study are not easily compared with other
data, because they were indexed to BSA1,3 and a reference
group is lacking. Anderson and associates4 showed a de-
crease in end-diastolic volume with increasing age and an in-
crease in mass/volume ratio. There was no increase in
ventricular mass with time as assessed with MRI. Echocar-
diographic data in that study suggest that the end-systolic
volume is relatively large compared to end-diastolic vol-
ume,4 which is in accordance with our findings. Eicken and
colleagues18 reported normal volumes and mass and de-
creased EF in patients 10 years after Fontan completion (at-
riopulmonary connection, right atrium to RV conduit, or
TCPC). After Fontan completion, dramatic changes in ven-
tricular geometry occur.19,20 In the early postoperative pe-
riod, there are decreases in ventricular dimensions and an
inappropriate degree of ventricular hypertrophy. Although
others have shown normalization of ventricular volumes
and mass with increasing follow-up time,18,20 we demon-
strated higher end-diastolic volumes, higher end-systolic
volumes, higher ventricular mass, and lower EF in Fontan pa-
tients than in the control group. Our observations that the
ventricle operates at an increased end-systolic volume with
normal systolic blood pressure suggests that arterial ela-
stance is increased.
Recently, Senzaki and colleagues21 found a higher ventric-
ular afterload in Fontan patients than in patients with a biven-
tricular circulation. These observations support experimental
data from Szabo´ and coworkers,22 who demonstrated contrac-
tility–afterload mismatch in an animal model of the Fontan
circulation. Earlier, we demonstrated well-preserved contrac-
tility with stress testing.15 This could explain the increase in
ventricular mass (and increase in mass/volume ratio relative
to control subjects) that we found in this group. As in patients
with aortic valve stenosis, we found an inverse correlation of
ventricular mass with EF.23 In isolated aortic valve stenosis,
increased LV mass predicts the presence of systolic dys-
function and heart failure, and LV hypertrophy as a reaction
to increased afterload may be maladaptive rather thanCardiovascular Surgery c Volume 138, Number 1 93
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to diastolic dysfunction in Fontan patients by Penny and co-
workers,24 who found evidence for the development of unco-
ordinated ventricular relaxation. The effects of increased
ventricular mass and the effects of contractility–afterload
mismatch on the long-term function of the single ventricle
must be investigated. Furthermore, together with the study
by Senzaki and colleagues,21 our study provides data sug-
gesting further clinical trials to investigate the effects of
long-term afterload reduction on systemic ventricular func-
tion in the Fontan circulation.
Several groups have investigated BNP or NT-pro-BNP
levels at short-term to midterm follow-up after the Fontan
operation.25-29 In these studies, levels were increased rela-
tive to control groups, but the value of BNP or NT-pro-
BNP seemed low for diagnostic or prognostic purposes.27
Only Hjortdal and associates29 found normalization of neu-
rohormones late after the Fontan operation. Law and col-
leagues28 concluded that BNP could discriminate between
patients with systemic ventricular failure (elevated BNP)
and those with isolated cavopulmonary failure (BNP not el-
evated). Man and Cheung25 found a correlation between
BNP and variables of diastolic function (most of their pa-
tients had undergone an atriopulmonary connection).
Under pathologic conditions, production of BNP rises
strongly in both atria and ventricles. In our study group, sys-
temic ventricular EDVI was only slightly higher than in the
control group. Therefore BNP release from ventricular myo-
cardial stretch is not to be expected. In this study, the number
of patients with NT-pro-BNP levels above the upper refer-
ence limit was small, preventing us from proper analysis
of NT-pro-BNP’s usefulness for risk stratification in Fontan
patients.
This study is limited by the size and characteristics of the
study group. Because of the small numbers, comparisons be-
tween different Fontan types or between different systemic
ventricular morphologic types should be made with caution.
As in most studies of Fontan patients, the study group is het-
erogeneous, and conclusions therefore may not be applicable
to all categories of patients. This group is not a representative
random sample of the entire TCPC population, because we
excluded patients with pacemakers and patients with neuro-
logic complications. This limitation prevents us from making
firm conclusions regarding the rhythm status of the overall
patient group.
In conclusion, patients at midterm follow-up after a Fontan
operation performed when they were younger than 5 years
were in acceptable clinical condition, with preserved global
ventricular function, moderately decreased exercise capac-
ity, and NT-pro-BNP levels within the reference range. Sys-
temic ventricular mass was elevated after the Fontan
operation, however, suggesting contractility–afterload mis-
match. The long-term consequences of this phenomenon
for ventricular function merit further investigation.94 The Journal of Thoracic and Cardiovascular SurgWe thank Dirk J. Duncker, MD, PhD (Department of Experi-
mental Cardiology, Erasmus MC, Rotterdam, the Netherlands)
for his contribution in the discussion on afterload mismatch.
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